Objective. - To determine the prevalence of migraine in patients,vith syste
mic lupus erythematosus (SLE), and to examine the relationships between hea
dache type and other clinical, serologic, and treatment features of the dis
ease.
Background.-Headaches are common in SLE and are a significant source of pat
ient disability. The exact prevalence of headaches in patients with SLE is
unknown. The classification of headache syndromes in SLE is also unclear. P
revious studies were based on small numbers of patients and the headache ty
pes and criteria to define headache types varied widely.
Methods. - Four hundred fourteen patients meeting American College of Rheum
atology criteria for the diagnosis of SLE: were sent the University of Cali
fornia, San Diego Migraine Questionnaire. Patients who completed the questi
onnaire had their medical records reviewed for constitutional, respiratory,
cardiac, vascular, skin, musculoskeletal, other neuropsychiatric, hematolo
gic, renal, and immunologic manifestations of the disease. Recent corticost
eroid, nonsteroidal anti-inflammatory drug, antimalarial, acid immunosuppre
ssive medications were also recorded.
Results. - One hundred eighty-six patients completed the questionnaire, Six
ty-two percent of patients reported headaches: 39% met diagnostic criteria
for migraine and 23% met criteria for nonmigrainous headache. Of the patien
ts with migraine, 56% met criteria for migraine without aura and 44% met cr
iteria for migraine with aura. There were no significant associations betwe
en headache type and other clinical, serologic, or treatment features of th
e disease.
Conclusions. - There is a high prevalence of migraine in patients with SLE,
and patients should be routinely evaluated for migraine symptoms.